Take control of your life!
You did not choose to get cancer.
But you can choose to get involved in your treatment.
|I-FIND||Find Promising treatment options personalized for you. Answer a few questions to see a short list of your best options today. More...|
|I-SHARE||Partner with us in testing promising therapies by donating your health information. More …|
|I-FUND||Fund clinical trials of IMMEDIATELY available promising treatments. More …|
GlobalCures is a non-profit medical research organization dedicated to curing patients with cancer and other diseases by rapidly promoting clinical research on scientifically promising, readily available and cost-effective treatments.
Our strategy is to re-purpose existing drugs, currently being overlooked for cancer use, due to lack of profitability.
Billions of dollars are spent each year on laboratory research, where enormous progress has been made in recent years. However, for the most part, only those basic science discoveries with high potential for financial reward have led to drugs for human use leaving behind many untapped opportunities.
Among these financially unrewarding promising therapies (“Fiscal Orphans”), are many FDA approved drugs which are immediately available for use for diseases other than what they were approved for. In addition, many generally regarded as safe (GRAS) substances like flax oil or nutraceuticals such as vitamin C have been studied in humans but have rarely undergone rigorous clinical trials and therefore are typically not recommended by physicians as treatment options.
GlobalCures believes that we now have a unique opportunity - indeed a responsibility - to research further and develop such therapies.
Our Unique Business Model:
The current for-profit model used by pharmaceutical companies was necessary to develop the many promising drugs that GlobalCures will 'reposition' for a different use.
GlobalCures has adopted a non-profit drug development model, so that the criteria used in evaluating the potential of a therapy will focus solely on scientific merit and not on financial reward.